Business Standard

Two existing drugs inhibit Coronavirus from infecting human cells: Study

The work, which will need to be replicated in human trials, suggests a potential new target for Covid-19 therapies

Malaysia detects new Covid-19 strain that's 10 times more infectious
Premium

The study found that apilimod and vacuolin-1 are very strong inhibitors for viral infection in the lab

Press Trust of India Boston
Two existing drugs inhibit SARS-CoV-2, the virus that causes Covid-19, from infecting human cells in the lab, a study has found.
According to the study, published in the journal PNAS, both drugs, vacuolin-1 and apilimod, originally developed years ago, target a large enzyme called PIKfyve kinase.
Before this study, little was known about this enzyme's role in Covid-19 infection, the researchers said.
The work, which will need to be replicated in human trials, suggests a potential new target for Covid-19 therapies, they said.
"Our findings show that targeting this kinase through a small-molecule antiviral against SARS-CoV-2 may be an effective strategy to lessen the progression or seriousness

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in